PMV Pharmaceuticals Inc — Liquidità Trimestrale (NASDAQ:PMVP)

Financials

Totale attivo 191.29 M170.61 M152.85 M133.84 M116.56 M Totale passività 15.21 M10.5 M12.25 M12.85 M11.85 M Patrimonio netto totale 176.08 M160.11 M140.6 M121 M104.71 M Totale passività e patrimonio netto 191.29 M170.61 M152.85 M133.84 M116.56 M Debito totale ————— Indebitamento netto —————

Notizie

Studio su rezatapopt di PMV Pharma pubblicato sul New England Journal

PMV Pharma’s rezatapopt study published in New England Journal

OrbiMed Advisors vende azioni PMV Pharma (PMVP) per 1,52 milioni di dollari

OrbiMed Advisors sells PMV Pharma (PMVP) shares for $1.52 million

PMV Pharmaceuticals, Inc. (PMVP) Presents at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Slideshow (NASDAQ:PMVP) 2025-10-25

Il titolo di PMV Pharmaceuticals sale su dati positivi del trial sul farmaco anticancro

PMV Pharmaceuticals stock rises on positive cancer drug trial data

PMV Pharma presenterà i dati iniziali sulla terapia per la mutazione TP53

PMV Pharma to present initial data on TP53 mutation therapy at cancer conference

PMV Pharmaceuticals mantiene rating Buy da H.C. Wainwright sui dati clinici

PMV Pharmaceuticals stock holds Buy rating at H.C. Wainwright on trial data

PMV Pharmaceuticals, Inc. (PMVP) Special Call - Slideshow (NASDAQ:PMVP)